Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-16T13:03:16.016Z Has data issue: false hasContentIssue false
  • English
  • Français

Anticuerpos antinucleares inducidos por neurolépticos

Published online by Cambridge University Press:  12 May 2020

J. L. Ayuso  and
J. Saiz Ruiz
J. L. Ayuso
Affiliation:
Hospital Clínico de San Carlos, Universidad Complutense, Departamento de Psiquiatría, Madrid;
J. Saiz Ruiz
Affiliation:
Hospital Ramón y Cajal, Universidad de Alcalá, Servicio de Psiquiatría, Madrid, España

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Cartas el editor
Information
European Psychiatry (Ed. Española) , Volume 4 , Issue 3 , April 1997 , pp. 201
Copyright
Copyright © European Psychiatric Association 1997

References

BIBLIOGRAFIA

Ayuso, JLSaiz-Ruiz, JCasimiro, C. Phenothiazine-induced antinuclear antibodies in psychiatric patients. IRCS Med Sci 1976; 4: 343.Google Scholar
Berglund, CGSGottfries, CGGottfries, IStormby, K. Chlorpromazine-induced antinuclear factors. Acta Med Scand 1970; 187: 67-74.CrossRefGoogle ScholarPubMed
Canoso, RTde Oliveira, RMNixon, RA. Neurolepticassociated autoantibodies. A prevalence study. Biol Psychiatry 1990; 27: 863-70.CrossRefGoogle ScholarPubMed
Gallien, MSchnetzler, JPMorin, J. Anticorps antinucléaires et lupus induits par les phénothiazines chez six cents malades hospitalisés. Ann Med Psychol 1975; 2: 237-48.Google Scholar
Spivak, BRadwan, MBartur, PMester, RWeizman, A. Antinuclear autoantibodies in relation to bipolar affective disorder and lithium therapy. Eur Psychiatry 1996; 11: 50-2.CrossRefGoogle ScholarPubMed